Cargando…
GNG12 as A Novel Molecular Marker for the Diagnosis and Treatment of Glioma
PURPOSE: GNG12 influences a variety of tumors; however, its relationship with glioma remains unclear. The aim of this study was to comprehensively investigate the relationship between GNG12 and the clinical characteristics and prognosis of glioma patients and reveal the mechanisms causing the malign...
Autores principales: | Liu, Runze, Liu, Zhendong, Zhao, Yaoye, Cheng, Xingbo, Liu, Binfeng, Wang, Yanbiao, Wang, Jialin, Lian, Xiaoyu, Zhu, Yongjie, Gao, Yanzheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345608/ https://www.ncbi.nlm.nih.gov/pubmed/35928884 http://dx.doi.org/10.3389/fonc.2022.726556 |
Ejemplares similares
-
Overexpression of GINS4 is associated with poor prognosis and survival in glioma patients
por: Liu, Binfeng, et al.
Publicado: (2021) -
ELK3: A New Molecular Marker for the Diagnosis and Prognosis of Glioma
por: Liu, Zhendong, et al.
Publicado: (2021) -
Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value
por: Zhang, Bo, et al.
Publicado: (2021) -
GNG5 is a novel oncogene associated with cell migration, proliferation, and poor prognosis in glioma
por: Zhang, Wang, et al.
Publicado: (2021) -
Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients
por: Liu, Zhendong, et al.
Publicado: (2021)